Allogene Therapeutics, Inc. (ALLO)
Latest ALLO Insider Trades
About Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
- SOUTH SAN FRANCISCO, CA
- 152
- 2018
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 29,697 | $63K |
| Grant or award | 9 | 1,327,520 | |
| Option exercise | 2 | 95,400 |
ALLO Insider Transactions (Form 4)
4529 Form 4 filings on record, the earliest from Oct 23, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Earl Martin Douglas - Officer | Open-market sale | Common Stock | 29,697 |
Recent ALLO Form 8-K Filings
5Recent ALLO Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Douglas Earl Martin | Officer | 29,697 | $63K | View on EDGAR | |
| - | - |
ALLO Insider Trading - FAQ
What is the latest insider trade for ALLO?
Allogene Therapeutics, Inc. (ALLO) had 9 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for ALLO runs to 29 Form 4 filings, the earliest from 2024-10-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ALLO stock?
No insider purchases of ALLO were filed in the last 90 days.
How many insiders are selling ALLO stock?
1 insider sale of ALLO was filed in the last 90 days, totaling $63K.
Where can I see ALLO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ALLO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ALLO insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ALLO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Earl Martin Douglas view on EDGAR
- - Zachary Roberts view on EDGAR
- - Joshua A. Kazam view on EDGAR
- - Deborah M. Messemer view on EDGAR
- - Stephen Mayo view on EDGAR
- - Vicki L. Sato view on EDGAR
- - Owen N. Witte view on EDGAR
- - Franz B. Humer view on EDGAR
- - Elizabeth A. Barrett view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ALLO's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ALLO insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
